Biju Vasudevan1, Amitabh Sagar2, Ashish Bahal3, Ap Mohanty4. 1. Classified Specialist (Dermatology), Command Hospital (SC), Pune - 40. 2. Associate Professor, Department of Medicine, AFMC, Pune - 40. 3. Classified Specialist (Pathology), Military Hospital, Secunderabad. 4. Commandant, Military Hospital, Shillong.
Abstract
BACKGROUND: Cutaneous manifestations are early and easily identifiable markers of human immunodeficiency virus (HIV) infection. They can help in predicting severity and progress of the disease and can be correlated well with CD4 counts. This study was undertaken to study the cutaneous manifestations of HIV infection and to correlate them with CD4 counts. It also aimed to study the changing spectrum of these manifestations and describe cutaneous manifestations seen in advanced disease. METHOD: A total of 234 HIV-positive patients not on anti-retroviral therapy, who attended the outpatient department or were admitted as inpatients at Military Hospital, Shillong during the period between May 2008 and October 2009 were included. Cutaneous, mucosal, and genitourinary manifestations in these patients were studied in detail and were correlated with CD4 counts. RESULTS: Infections were the most common group of mucocutaneous manifestations, while onychomycosis was the commonly observed individual manifestation. A different set of cutaneous markers for advanced HIV disease was observed and new parameters for therapy were also arrived at. CONCLUSION: Specific morphological variants of cutaneous markers may provide a better clue to early diagnosis of HIV and can help in diagnosing advanced stages of the disease. Fresh cutaneous markers are required for indicating cut-off levels of CD4 count at 350/μL for starting therapy.
BACKGROUND: Cutaneous manifestations are early and easily identifiable markers of human immunodeficiency virus (HIV) infection. They can help in predicting severity and progress of the disease and can be correlated well with CD4 counts. This study was undertaken to study the cutaneous manifestations of HIV infection and to correlate them with CD4 counts. It also aimed to study the changing spectrum of these manifestations and describe cutaneous manifestations seen in advanced disease. METHOD: A total of 234 HIV-positive patients not on anti-retroviral therapy, who attended the outpatient department or were admitted as inpatients at Military Hospital, Shillong during the period between May 2008 and October 2009 were included. Cutaneous, mucosal, and genitourinary manifestations in these patients were studied in detail and were correlated with CD4 counts. RESULTS: Infections were the most common group of mucocutaneous manifestations, while onychomycosis was the commonly observed individual manifestation. A different set of cutaneous markers for advanced HIV disease was observed and new parameters for therapy were also arrived at. CONCLUSION: Specific morphological variants of cutaneous markers may provide a better clue to early diagnosis of HIV and can help in diagnosing advanced stages of the disease. Fresh cutaneous markers are required for indicating cut-off levels of CD4 count at 350/μL for starting therapy.
Authors: A K Gupta; P Taborda; V Taborda; J Gilmour; A Rachlis; I Salit; M A Gupta; P MacDonald; E A Cooper; R C Summerbell Journal: Int J Dermatol Date: 2000-10 Impact factor: 2.736
Authors: P K Kaviarasan; T J Jaisankar; Devinder Mohan Thappa; S Sujatha Journal: Indian J Dermatol Venereol Leprol Date: 2002 Jul-Aug Impact factor: 2.545
Authors: A R Lifson; J F Hilton; J L Westenhouse; A J Canchola; M C Samuel; M H Katz; S P Buchbinder; N A Hessol; D H Osmond; S Shiboski Journal: AIDS Date: 1994-01 Impact factor: 4.177
Authors: Saskya Claasens; Susanna M H Kannenberg; Henry F Jordaan; Karis Moxley; Rhodine Smith; Johann de Wet; Willem I Visser Journal: South Afr J HIV Med Date: 2020-12-10 Impact factor: 2.744